These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33238908)

  • 21. Association Between Proxy- or Self-Reported Cognitive Decline and Cognitive Performance in Memory Clinic Visitors.
    Gruters AAA; Ramakers IHGB; Verhey FRJ; Köhler S; Kessels RPC; de Vugt ME
    J Alzheimers Dis; 2019; 70(4):1225-1239. PubMed ID: 31322557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.
    Di Carlo A; Baldereschi M; Lamassa M; Bovis F; Inzitari M; Solfrizzi V; Panza F; Galluzzo L; Scafato E; Inzitari D;
    J Alzheimers Dis; 2016 May; 53(2):505-15. PubMed ID: 27163817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of a cognitive training therapy based on stimulation of brain oscillations in patients with mild cognitive impairment in a Chilean sample: study protocol for a phase IIb, 2 × 3 mixed factorial, double-blind randomised controlled trial.
    Figueroa-Vargas A; Góngora B; Alonso MF; Ortega A; Soto-Fernández P; Z-Rivera L; Ramírez S; González F; Muñoz Venturelli P; Billeke P
    Trials; 2024 Feb; 25(1):144. PubMed ID: 38395980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. White Matter Hyperintensity Predicts the Risk of Incident Cognitive Decline in Community Dwelling Elderly.
    Ding D; Xiong Y; Zhao Q; Guo Q; Chu S; Chu WWC; Luo J; Liang X; Zheng L; Hong Z; Wong LKS; Mok VCT
    J Alzheimers Dis; 2018; 61(4):1333-1341. PubMed ID: 29376875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Progression of Subjective Cognitive Decline Among Rural Chinese Older Adults: A Population-Based Study.
    Xu S; Ren Y; Liu R; Li Y; Hou T; Wang Y; Wang X; Wang L; Monastero R; Du Y; Cong L; Qiu C
    J Alzheimers Dis; 2023; 93(4):1355-1368. PubMed ID: 37182880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
    Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
    JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway.
    Strand BH; Knapskog AB; Persson K; Edwin TH; Amland R; Mjørud M; Bjertness E; Engedal K; Selbæk G
    PLoS One; 2018; 13(9):e0204436. PubMed ID: 30240425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study.
    Thingstad P; Askim T; Beyer MK; Bråthen G; Ellekjær H; Ihle-Hansen H; Knapskog AB; Lydersen S; Munthe-Kaas R; Næss H; Pendlebury ST; Seljeseth YM; Saltvedt I
    BMC Neurol; 2018 Nov; 18(1):193. PubMed ID: 30477436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MyCOACH (COnnected Advice for Cognitive Health): a digitally delivered multidomain intervention for cognitive decline and risk of dementia in adults with mild cognitive impairment or subjective cognitive decline-study protocol for a randomised controlled trial.
    Amos JG; Zheng L; Eramudugolla R; Parekh D; Huque MH; Delbaere K; Lautenschlager N; Anstey KJ
    BMJ Open; 2023 Oct; 13(10):e075015. PubMed ID: 37903606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a multicomponent exercise programme (VIVIFRAIL) on functional capacity in frail community elders with cognitive decline: study protocol for a randomized multicentre control trial.
    Casas-Herrero A; Anton-Rodrigo I; Zambom-Ferraresi F; Sáez de Asteasu ML; Martinez-Velilla N; Elexpuru-Estomba J; Marin-Epelde I; Ramon-Espinoza F; Petidier-Torregrosa R; Sanchez-Sanchez JL; Ibañez B; Izquierdo M
    Trials; 2019 Jun; 20(1):362. PubMed ID: 31208471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Operationalizing the Diagnostic Criteria for Mild Cognitive Impairment: The Salience of Objective Measures in Predicting Incident Dementia.
    Brodaty H; Aerts L; Crawford JD; Heffernan M; Kochan NA; Reppermund S; Kang K; Maston K; Draper B; Trollor JN; Sachdev PS
    Am J Geriatr Psychiatry; 2017 May; 25(5):485-497. PubMed ID: 28110876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of progression from subjective cognitive decline to objective cognitive impairment: A systematic review and meta-analysis of longitudinal studies.
    An R; Gao Y; Huang X; Yang Y; Yang C; Wan Q
    Int J Nurs Stud; 2024 Jan; 149():104629. PubMed ID: 37979370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased reporting of subjective cognitive complaints over time predicts cognitive decline and incident dementia.
    Numbers K; Lam BCP; Crawford JD; Kochan NA; Sachdev PS; Brodaty H
    Int J Geriatr Psychiatry; 2021 Nov; 36(11):1739-1747. PubMed ID: 34216392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaint.
    Belleville S; Moussard A; Ansaldo AI; Belchior P; Bherer L; Bier N; Bohbot VD; Bruneau MA; Cuddy LL; Gilbert B; Jokel R; Mahalingam K; McGilton K; Murphy KJ; Naglie G; Rochon E; Troyer AK; Anderson ND
    Trials; 2019 May; 20(1):282. PubMed ID: 31118095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial.
    Whitfield T; Demnitz-King H; Schlosser M; Barnhofer T; Frison E; Coll-Padros N; Dautricourt S; Requier F; Delarue M; Gonneaud J; Klimecki OM; Lutz A; Paly L; Salmon E; Schild AK; Walker Z; Jessen F; Chételat G; Collette F; Wirth M; Marchant NL;
    Alzheimers Res Ther; 2022 Sep; 14(1):125. PubMed ID: 36068621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia.
    Guo J; Wang J; Dove A; Chen H; Yuan C; Bennett DA; Xu W
    JAMA Psychiatry; 2022 Dec; 79(12):1180-1187. PubMed ID: 36287554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Subjective Cognitive Decline With Progression to Dementia in a Cognitively Unimpaired Multiracial Community Sample.
    Chapman S; Rentería MA; Dworkin JD; Garriga SM; Barker MS; Avila-Rieger J; Gonzalez C; Joyce JL; Vonk JMJ; Soto E; Manly JJ; Brickman AM; Mayeux RP; Cosentino SA
    Neurology; 2023 Mar; 100(10):e1020-e1027. PubMed ID: 36450605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in quantitative methods for measuring subjective cognitive decline - results from a prospective memory clinic study.
    Vogel A; Salem LC; Andersen BB; Waldemar G
    Int Psychogeriatr; 2016 Sep; 28(9):1513-20. PubMed ID: 27053171
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.